Table 2.
Factors | Univariate linear regression |
Multivariate linear regression |
||
---|---|---|---|---|
B (95% CI) | p-value | B (95% CI) | p-value | |
Age | −0.041 (−0.283, 0.201) | 0.739 | ||
Gender | −2.143 (−8.045, 3.758) | 0.473 | ||
Educational Level | 6.357 (1.013, 11.701) | 0.020 | 3.038 (−1.127, 7.203) | 0.151 |
Epilepsy Duration | −0.02 (−0.278, 0.238) | 0.880 | ||
Achieved regular outpatient consultation | 5.315 (−5.386, 16.015) | 0.327 | ||
Treatment change in the last year | −10,105 (−16,863, −3,346) | 0.004 | −2.494 (−7.923, 2.935) | 0.364 |
Patient is currently employed | −0.467 (−6.391, 5.458) | 0.876 | ||
Temporary suspension or permanent termination of employment | −5.140 (−13.761, 3.482) | 0.240 | ||
Significant reduction in household income | −9.293 (−15.117, −3.469) | 0.002 | 2.426 (−2.910, 7.762) | 0.369 |
Fear of seizures | −10.271 (−12.885, −7.658) | <0.001 | −8.562 (−11.379, −5.745) | <0.001 |
Fear of drug supply disruption | −3.377 (−6.608, −0.146) | 0.041 | −0.633 (−3.544, 2.279) | 0.667 |
Fear of inability to reach neurologist | −4.699 (−7.059, −2.339) | <0.001 | −2.085 (−4.474, 0.303) | 0.086 |
Fear of reduction in household income | −5.946 (−8.896, −2.996) | <0.001 | −4.376 (−7.030, −1.723) | 0.001 |
Fear of COVID-19 | −2.014 (−4.857, 0.829) | 0.163 | ||
Contact with COVID-19 positive person | 0.180 (−6.020, 6.381) | 0.954 | ||
History of PCR confirmed COVID-19 | 2.371 (−5.586, 10.329) | 0.555 | ||
History of recognizable symptoms of COVID-19 | 0.186 (−8.233, 8.605) | 0.965 |
SVQOLIE-31 - Serbian version of the Quality of Life in Epilepsy-31.